Details for Patent: 11,471,409
✉ Email this page to a colleague
Which drugs does patent 11,471,409 protect, and when does it expire?
Patent 11,471,409 protects KATERZIA and is included in one NDA.
This patent has six patent family members in five countries.
Drugs Protected by US Patent 11,471,409
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Azurity | KATERZIA | amlodipine benzoate | SUSPENSION;ORAL | 211340-001 | Jul 8, 2019 | RX | Yes | Yes | 11,471,409 | ⤷ Subscribe | A METHOD OF TREATING CORONARY ARTERY DISEASE | ⤷ Subscribe | ||||
Azurity | KATERZIA | amlodipine benzoate | SUSPENSION;ORAL | 211340-001 | Jul 8, 2019 | RX | Yes | Yes | 11,471,409 | ⤷ Subscribe | A METHOD OF TREATING HYPERTENSION | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,471,409
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 3096101 | ⤷ Subscribe | |||
China | 112334134 | ⤷ Subscribe | |||
European Patent Office | 3773574 | ⤷ Subscribe | |||
Japan | 2021520367 | ⤷ Subscribe | |||
Japan | 7456933 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |